Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Mott

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Annals of Hematology|June 6, 2026
Splicing factor mutations clearance and outcomes in clonal myeloid neoplasms: a referral center experienceManasawee Tanariyakul, Sarah Mott, Bethany Daniels, et al.
Ejhaem|June 19, 2024
Clinical outcomes of patients receiving three versus four doses of methotrexate with concomitant antithymocyte globulin in match unrelated donor allogeneic stem cell transplant: A single-center experienceKittika Poonsombudlert, Sarah Mott, Benda Miller, et al.
American Journal of Nuclear Medicine and Molecular Imaging|November 29, 2017
Safety and accuracy of <sup>68</sup>Ga-DOTATOC PET/CT in children and young adults with solid tumorsChenue Abongwa, Sarah Mott, Blanca Schafer, et al.
Biochemistry|April 28, 2004
Probing domain mobility in a flavocytochromeEmma L Rothery, Christopher G Mowat, Caroline S Miles, et al.
European Journal of Haematology|March 19, 2025
Effect of NPM1 Mutation Subtype and Co-Mutation Patterns on the Outcomes of Acute Myeloid LeukemiaKittika Poonsombudlert, Ratdanai Yodsuwan, Sarah Mott, et al.
Cancer|February 17, 2026
A phase 1b/2 study of cabozantinib in combination with pembrolizumab in advanced cutaneous melanomaYousef Zakharia, Donghyun Kim, Michele Freesmeier, et al.
European Journal of Haematology|March 21, 2024
Transplant versus no transplant in myelodysplastic syndrome and acute myeloid leukemia with TP53 mutation; a referral center experienceKittika Poonsombudlert, Sarah Mott, Benda Miller, et al.
Urologic Oncology|June 1, 2025
Avelumab and taxol chemotherapy in platinum-refractory or ineligible metastatic urothelial carcinoma (AVETAX trial)Rohan Garje, Aditya Ravindra, Bilal Rahim, et al.
Thorax|January 30, 2013
Authors' responseLauren Sarah Mott, Judy Park, Conor P Murray, et al.
Journal for Immunotherapy of Cancer|July 31, 2021
Intratumoral talimogene laherparepvec injection with concurrent preoperative radiation in patients with locally advanced soft-tissue sarcoma of the trunk and extremities: phase IB/II trialVarun Monga, Benjamin J Miller, Munir Tanas, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Annals of Hematology|June 6, 2026
Splicing factor mutations clearance and outcomes in clonal myeloid neoplasms: a referral center experienceManasawee Tanariyakul, Sarah Mott, Bethany Daniels, et al.
Ejhaem|June 19, 2024
Clinical outcomes of patients receiving three versus four doses of methotrexate with concomitant antithymocyte globulin in match unrelated donor allogeneic stem cell transplant: A single-center experienceKittika Poonsombudlert, Sarah Mott, Benda Miller, et al.
American Journal of Nuclear Medicine and Molecular Imaging|November 29, 2017
Safety and accuracy of <sup>68</sup>Ga-DOTATOC PET/CT in children and young adults with solid tumorsChenue Abongwa, Sarah Mott, Blanca Schafer, et al.
Biochemistry|April 28, 2004
Probing domain mobility in a flavocytochromeEmma L Rothery, Christopher G Mowat, Caroline S Miles, et al.
European Journal of Haematology|March 19, 2025
Effect of NPM1 Mutation Subtype and Co-Mutation Patterns on the Outcomes of Acute Myeloid LeukemiaKittika Poonsombudlert, Ratdanai Yodsuwan, Sarah Mott, et al.
Cancer|February 17, 2026
A phase 1b/2 study of cabozantinib in combination with pembrolizumab in advanced cutaneous melanomaYousef Zakharia, Donghyun Kim, Michele Freesmeier, et al.
European Journal of Haematology|March 21, 2024
Transplant versus no transplant in myelodysplastic syndrome and acute myeloid leukemia with TP53 mutation; a referral center experienceKittika Poonsombudlert, Sarah Mott, Benda Miller, et al.
Urologic Oncology|June 1, 2025
Avelumab and taxol chemotherapy in platinum-refractory or ineligible metastatic urothelial carcinoma (AVETAX trial)Rohan Garje, Aditya Ravindra, Bilal Rahim, et al.
Thorax|January 30, 2013
Authors' responseLauren Sarah Mott, Judy Park, Conor P Murray, et al.
Journal for Immunotherapy of Cancer|July 31, 2021
Intratumoral talimogene laherparepvec injection with concurrent preoperative radiation in patients with locally advanced soft-tissue sarcoma of the trunk and extremities: phase IB/II trialVarun Monga, Benjamin J Miller, Munir Tanas, et al.
Pageof 4